1. Home
  2. PESI vs GBIO Comparison

PESI vs GBIO Comparison

Compare PESI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PESI
  • GBIO
  • Stock Information
  • Founded
  • PESI 1990
  • GBIO 2016
  • Country
  • PESI United States
  • GBIO United States
  • Employees
  • PESI N/A
  • GBIO N/A
  • Industry
  • PESI Environmental Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PESI Industrials
  • GBIO Health Care
  • Exchange
  • PESI Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • PESI 186.4M
  • GBIO 29.2M
  • IPO Year
  • PESI 1992
  • GBIO 2020
  • Fundamental
  • Price
  • PESI $11.07
  • GBIO $0.34
  • Analyst Decision
  • PESI
  • GBIO Strong Buy
  • Analyst Count
  • PESI 0
  • GBIO 4
  • Target Price
  • PESI N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • PESI 124.4K
  • GBIO 1.1M
  • Earning Date
  • PESI 08-07-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • PESI N/A
  • GBIO N/A
  • EPS Growth
  • PESI N/A
  • GBIO N/A
  • EPS
  • PESI N/A
  • GBIO N/A
  • Revenue
  • PESI $59,419,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • PESI $23.71
  • GBIO N/A
  • Revenue Next Year
  • PESI $86.33
  • GBIO N/A
  • P/E Ratio
  • PESI N/A
  • GBIO N/A
  • Revenue Growth
  • PESI N/A
  • GBIO 146.47
  • 52 Week Low
  • PESI $6.25
  • GBIO $0.30
  • 52 Week High
  • PESI $16.25
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • PESI 67.56
  • GBIO 45.19
  • Support Level
  • PESI $9.78
  • GBIO $0.31
  • Resistance Level
  • PESI $10.60
  • GBIO $0.37
  • Average True Range (ATR)
  • PESI 0.34
  • GBIO 0.03
  • MACD
  • PESI 0.05
  • GBIO -0.00
  • Stochastic Oscillator
  • PESI 84.87
  • GBIO 39.09

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: